Roche announces results from Evrysdi (risdiplam) study in infants with Type 1 spinal muscular atrophy (SMA) published in New England Journal of Medicine

Amy Giles
Increasing Engagement

David Linetsky
Point-of-Care Marketing

Liz Kane
Impactful Strategy

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Brenda Snow
Authentic Patient Voice

Stacey Gandler
Brand Nourishment

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access